Skip to content
Screener

Shattuck Labs, Inc. STTK Operating Income

Operating Income at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$7.14B+7.4%
Amgen logo
AmgenAMGN
$3.51B+32.3%
AbbVie logo
AbbVieABBV
$6.43B+31.4%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
-$24.24M-31.7%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$31.52M-63.2%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-$57.25M+24.5%

Segments

By segment

See full
Reportable Segment-$16.16M-24.0%

Other financials

Income statement

See full
Revenue-
Net income-$15.2M-21.6%
EPS (diluted)-$0.12+50.0%

Balance sheet

See full
Cash & equivalents$63.3M+25.4%
Total debt$2.7M-10.0%
Total equity$211.1M+270%
Total assets$220.7M+243%

Cash flow

See full
Operating cash flow-$10.2M+2.4%
CapEx$78.0K
Free cash flow-$10.3M+1.6%

Valuation

See full
Market cap$694.34M+1,861%
Enterprise value$633.72M-5,344%
P/S694.3×+683×

Profitability

See full
Operating margin-5,578.7%-15,316pp
Net margin-5,256.8%-14,625pp
FCF margin-4,124%-23,818pp

Returns & leverage

See full
Return on equity-39.2%-12.5pp
Debt / equity0.0×
Current ratio27.6×+17.3×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Shattuck Labs, Inc.’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 6:57 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-055483
RevenueThree Months Ended June 30, 2026 / $Three Months Ended June 30, 2026 / —Three Months Ended June 30, 2025 / $Three Months Ended June 30, 2025 / —Six Months Ended June 30, 2026 / $Six Months Ended June 30, 2026 / —Six Months Ended June 30, 2025 / $Six Months Ended June 30, 2025 / —
Research and development11,7008,68022,64618,599
General and administrative4,4554,3529,0538,822
Expense from operations16,15513,03231,69927,421
Loss from operations(16,155)(13,032)(31,699)(27,421)
Other income (expense)
Interest income1,0298041,8321,416
Other expense(26)(230)(52)(155)
Total other income1,0035741,7801,261

Item 1. Condensed Financial Statements (Unaudited)

FAQ

What is Shattuck Labs, Inc.'s operating income?
Shattuck Labs, Inc. (STTK) reported operating income of -$16.16M in Q2 2026.
How has Shattuck Labs, Inc.'s operating income changed year-over-year?
Shattuck Labs, Inc.'s operating income decreased by 24.0% year-over-year, from -$13.03M to -$16.16M.
What is the long-term trend for Shattuck Labs, Inc.'s operating income?
Over 3 years (2022 to 2025), Shattuck Labs, Inc.'s operating income has grown at a -20.7% compound annual growth rate (CAGR), from -$103.33M to -$51.51M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Ask your AI about Shattuck Labs, Inc.'s operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude